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Setological follow-up studies for up to 4 years on the levels of IgG antibody to
EBV-determined nuclear antigen (EBNA) were carried out on 36 patients with
on^. pha"yng""I coreln. in" (NPC). Th, strum harel^ of IgA antib, dy syneifi. to
EBV capsid antigen (VCA) were also measured in some of the particnts. The
titers of EBNA antibody were measured by enzyme-linked jinmunosorbent assay
(ELISA) and thus. of IgA antib, dy to \ICA w, re mon^u""d by th" in dire. t jin-
inunoftuorescence method. The EBNA antibody titers in most sera from the
patients before radiation therapy were found to be at least + times the nTcan values
in the sera of healthy control adults. within 2 to 8 months after completion of
therapy by 4-M\I Iiniac X-ray irradiation with total doses of 60 to 80 Gy, the titers
of EBNA antibody in the sera of 6 patients had returned to normal levels, and low
Ievcls of EBNA antibody were maintained for a long time after therapy. These
setological data were assodated with a good clinical prognosis without recurrence
or metastases. But in 6 patients, the patterns of change in the EBNA antibody
levels were different : the levels remained high after thcrapy or first decreased to
the normal level and then rose to at least 4 times this level. These 6 patients show-
ed recurrence or metastases. The patterns of change in the EBNA antibody levels
were well correlated with those of change in the levels of IgA antibody specific to
VCA. These changes in the levels of EB\I specific antibody could be detected
long before clinical symptoms of recurrence or metastasis, suggesting the usefulness
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of serological follow-up studies on EBV-specific antibody, for early prediction of
the prognosis of patients with NPC after radiation therapy.
INTRODUCTION
An association of Epstein-Barr virus (EBV)
with riasopharyngeal carcinoma (NPC) was
first rugg, st. d by Old at a1. (1966), and rub-
^, qu*ntly d. in, net"at"d by Hanl, .t a1. (1977),
and Z. rig ,t a1. (1979, 1982) wh, co""red .ut
setoepidemiological studies on EBV-specific
antibodies in sera from NPC patients and
normal individuals in China. Furthermore,
the detection of EBV-specific DNA in NPC
tissues (Desgranges at a1. , 1982) and of reac-
tivation of latent EBV in the riasopharynx at
th, .user of NPC (d" The, 1982) st". rigly
support the association of EBV with NPC.
EB\I-determined nuclear antigen (EBNA) is
an early virus-specific antigen appearing in
cells infected with EBV. Serum antibody to
EBNA was found at higher levels in patients
with NPC and Burkitt's lymphoma than in
those with other cancers (\10nka and HITSch,
1982). EBNA is thought to be important in
carcinogenesis by EBV (Klein and Klein,
1984). Serum antibody to EBNA can be
detected by indirect anti-complement jin-
inunoftuorescence (ACTF) using acetone-fixed
EBNA-positive Raji cells as antigen.
Recently, we developed an enzyme-linked
jinmunosorbent assay (ELISA) for detection
of EBNA antibody using a nuclear extract of
Rail cells as soluble antigen, and reported that
this method was more useful than ACIF
(Shimakage at a1. 1986). This coinmunica-
tion reports the use of this ELISA method in
serological follow-up studies on NPC pa-
tients.
1987 were studied. All patients were diagnosed as
poorly differentiatedhaving tindifferentiated
squamous cell carcinoma of the riasopharynx by
histological examination of biopsy tissue. The
patients were at stage 111 or IV, according to the
definition of stages of NPC. All patients had
received 4-MV jiniac X-ray, irradiation with total
doses of 60 to 80 Gy. Their ages at their first \, isit
to the Center ranged from 17 to 77 (mean age, 52.7
years). The sex ratio of men to women was 26: 10.
Sera were collected from the patients before and at
various times after the start of radiatioil therapy and
were stored at -+O C
or
2. Cell 0111ti, , e
Rail, an EBV-positive African Burkitt lymphoma
cell line, and BJAB, an EBV-negative lymphoma
cell line, were grown in RPlv'11 1640 medium sup-
piemented with 896 fetal calf serum
IVIATERIALS AND IvlETHODS
3. ELISA
For preparation of soluble antigen, nuclei were
prepared from Raji cells by fraction ation of nuclei
in hypotonic buffer 110 inM Tris-HCl (pH 7.0),
10 inM NaC1, 1.5 inM MgC12, I inM FMSF
(phenylmethylsulfonyMuoride)l and centrifugation.
The nuclei were solubilized in disruption buffer
120 inM Tris-HCl (pH 8.0), I inM 2-me Tonpto-
ethanol, 0.5 inM FMSF, I inM EDTA, 0.4 M NaCll
and centrifuged for 15 min at 10,000xg. The
supernatant was collected and Lised as antigen
Each well of a 96-well microplate was coated with
antigen (511g protein) and was blocl<ed by I%
bovine serum albumin for 3 h at 37 C. The test
serum was diluted serial Iy 2-fold, and 25 pi of each
dilution was added to wells. After incubation for
8 h at 4 C, tinbound antibodies were washed off,
and peroxidase-conjugated goat anti-I\urnan IgG
(I-chain specific, Tago Inc. ) was added to each well.
After incubation for 90 min at room temperature,
the wells were washed, and 0.4% 0-phenylenedia-
mine and 0.01q, }1202 were added to each well as
substrate for peroxidase. The reaction was stopped
by addition of + N H2SO, , and the absorbance was
I. 8116^^CtS
Thirty-six patients with NPC who visited the
Center for Adult Diseases, Osaka from 1983 to
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measured at 495 rim. For determination of positive
ELISA, a 0.05 higher absorbance value than tlTe
value in the control (witl, out test scrum and without
antigen) \\, as tai<en as the cut off \, alue. Tl\e anti-
body titer to EBNA \\, as expressed as the reciprocal











4. Ilemngg/11/11/'11'o71 171h, itfro, , (111) Tesi
Tl, e titers of antibodies to measles and rubella
were tested by Hl according to the instructions in
the manual standardized b\. tite National Institute
of H"filth (Tokyo, lap"n)
5. I, Ithrect 111,111,1110. fillo, 'CSce, it, 81n, ', 1111"
For titration of IgA antibody specific to EBV
capsid antigen (VCA). VCA slides were obtained
commercially from waito Pure Chemical Industries,
Osaka. Acetone-fixed P3HR-I cells smeared on
wells of VCA slides \\, CTe incubated \\, ith 10 pi
volumes of serial Iy diluted sera for 30 min at 37 C,
washed twice with PBS, and incubated for 30 min
at 37 C \\, ith diluted (I : 30) fluorescein isothio-
cyanate conjugated goat anti-human IgA (, r-chain























Of 36 NPC patients, 19 patients were fol-
lowed up for 4 months to 8 years after coin-
PIGtion of Iiniac X-ray radiation therapy with
total doses of 60 to 80 Gy, and sera were ob-
tained from them before therapy and at various
intervals of 2 to 39 months after therapy.
The sera from the other 17 patients were ob-
tained at various times before or after therapy
As controls, sera were obtained from 23
healthy adults. The 19 NPC patients were
divided into two groups, A (good prognosis)
and B (poor prognosis), based on clinical
evaluation in 1987, and the other 17 NPC
patients were grouped into C. Table I shows
the geometric mean titers of EBNA antibody
measured by ELISA. Before radiation
therapy, the mean titers of EBNA antibody
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FIGURr I. Changes in EBNA-specific IgG antibody titers of individual NPC patients before and after ra-
dintion therapy. The thicl< horizontal line in each panel shows the geometric mean titer of EBNA antibody
of 23 sera from healthy controls cited from Table I
Panel A: EBNA antibody levels of individual cases in group A, \vllOSe prognosis \\, as evaluated as good \\, Ith
no recurrence or metastasis up to the time of the latest clinical examination
Panel B: ERNA antibody levels of individual cases in group B, \\, hose prognosis \\, as poor, with evidence of
recurrence ( * ), or metastasis (*I:) or death ( + )
than in healthy adults. There was no signi-
ficant difference in the mean antibody titers
in the sera of the two groups of patients, A
and B before therapy, whereas a significant
difference in the mean titers of EBNA anti-
body in the sera of the two groups was seen
alto ther, py (p<0.05).
Fig. I shows the titers of EBNA antibody in
the individual NPC patients classified in
groups A and B in Table I and followed up
for various periods. The mean titers of
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shown by thick soncl lines parallel with the
abscissa in Fig. IA and B. The titers of
EBNA antibody in the sera of individual pa-
tients during the periods of therapy or Im-
mediate Iy after completion of therapy were
not essentially different from those before
therapy. None of the patients in group A
showed recurrence or metastasis. The three
cases numbered (1), (2) and (3) have been fol-
lowed up for 16 months, and have shown, no
clinical signs of recurrence or metastasis, but
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FIGURE 2. Correlation of changes in titers of EBNA-specific IgG antibody with those of VCA-specific IgA
antibody in four NPC patients, in comparison \\ith changes in the titers of Hl antibodies specific to measles
and rubella viruses. The thick line on the abscissa indicates the period of irradiation. The intervals of time
on the abscissa are arbitrary, for simplified demonstration of patterns. Panels A and B sho\\. \, alues for in-
dividual patients evaluated as having a good prognosis, and those in panels C and D are \, alues for patients
judged to have a poor prognosis
PanelA: Case (2) shown by .-. in Fig. IA. (.-.), EBNAjlgG antibody; (A-A), VCAjlgA antibody;








































recurrences and metastases were seen within
24 in. nth^ alter. rodiati. n ther, py (Fig. TB)
and Sato and Miyahara reported 46.77, sur-
vival three years after therapy (1977). The
antibody titers of 6 patients in group A de-
creased progressive Iy to the levels of normal
healthy adults within 2 to 8 months after the
.. inplati, n of therapy (Fig. IA). On th,
other hand, the patients in group B who main-
wined high titers (20,480) of EBNA antib. dy
showed recurrence of NPC in the pharynx or
metastasis (cases 4.5,6 and 7), and the two
patients (cases 8 and 9) whose EBNA anti-
body levels first decreased to normal levels
and at later' increased 4-fold, also showed
recurrence or metastasis (Fig. IB).
The patterns of EBNA antibody levels
after therapy in group B, that is either per-
sistence of a high level or first decrease fol-
lowed by 4-fold Increase, were not seen in
any case in group A. These characteristic
patterns of change in EBNA antibody levels
could be detected in several cases long before
the appearance of clinical symptoms of recur-
Tence or metastasis. These results suggest
that follow-up studies on EBNA antibody
levels after radiation therapy are helpful for
prediction of the prognosis.
For determination of whether decrease in
the level of EBNA antibody after local radia-
tion therapy was due to a general jinmuno-
suppressive effect on antibody producing B
cells or to a selective Inhibitory and destruc-
tive effect on EBV-carrying cells, the follow-
ing two tests were made.
The antibody levels to measles and rubella
in the sera of two NPC patients each in group
A and B respectively, \\, ere tested before and
after radiation therapy. As shown in Fig. 2,
no change was seen in the Hl titers of anti-
bodies to measles and rubella in the period
after therapy. Thus the changes in the anti-
body levels to EBNA appear to be specific
responses to radiation therapy.
To confirm this possibility, we measured
the levels of another antibody specific to
EBV, and characteristic of NPC, that is, serum
IgA antib. dy to EBV-."usid antig, n (VCA),
a late antigen synthesized after the synthesis
of viral genomic DNA. The serum level of
IgA antibody to VCA was measured by in-
direct jinmunofluorescence, and the results
are also shown in the 4 panels in Fig. 2. The
patterns of changes in the IgA antibody levels
to VCA were very similar to those of the
changes in the IgG antibody levels to EBNA
These results suggest that the changes in the
EBV-specific antibody levels in NPC patients
are correlated with the replication of EBV,
and that the clinical progression of NPC, such
as recurrence or metastasis Is associated with
replication of EBV, possibly due to its re-
activation.
DISCUSSION
PanelB: The cose shown by O-O in Fig. IA. (0-0), EBNAjlgG; (A-A), VCAjlgA
Pan"I C: are (9) *h. wn by O-Qin Fig. IB. (0-0), EBNAjlgG; (A-A), VCAllgA
PanelD: Case (8) shown by v-v in Fig. IB. (v-V), EBNAjlgG; (A-A)
.---. and .---. in panels B, C and D represent Hl antibodies to rubella and measles viruses, respectiveI, ,
as described in panel A
There are many reports of association of latent
or persistent EBV-infection with the occur-
Tence of NPC, Burkitt's lymphomas, and
lymphomas under cellular jinmunosuppressive
or jinmunodeficient conditions, some of which
are related to organ transplantation (Cleary
et a1. , 1985). However, there are few reports
of EBV-related serological follow-up studies
on NPC patients for a long time after radia-
tion therapy. Our data are similar to those
rep. rt*d by Hanl, at ,I. (1977) and T"mad,
et a1. (1984), but we found that the time re-
quired for decrease in the levels of EBNA
antibody determined by ELISA was shorter
than those reported by these investigators
Our data showed that maintenance of nearly
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normal EBNA antibody levels for at least three
years after radiation therapy was a good in-
dication of a good prognosis of NPC patients
without recurrence or metastasis, and that
radiation therapy may, controll replication of
EBV. In about 559', of the patients in group
B, the antibody levels to EBNA and \;CA
were not maintained at nearly normal levels,
and these patients showed a poor clinical
course \\, Itit recurrence or metastasis. In
these patients, replication and reactivation of
EBV appeared to be one factor involved in
the poor prognosis after radiatioi\ therapy
But, the other 457, of the patients in group B
also showed a poor clinical course although
their titers of EBNA antibody were low. In
these patients, the recurrence and metastasis
must have been caused by other factors than
EBV, suclT as 10\\, cellular immunity as in-
dint"d by Sinnki (1987)
Various factors are probably related to the
of NPC. Our data indicate thatprognosis
one of these is EB\I since it is related not only
to the onset of NPC, but also to the progres-
SIon of this disease during the period after
therapy
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